Stockreport

Tetraphase Pharmaceuticals Presents Preclinical Data on TP-2846, a Novel Drug Candidate for Acute Myeloid Leukemia

TETRAPHASE PHARMACEUTICALS INC  (TTPH) 
Last tetraphase pharmaceuticals inc earnings: 3/11 09:29 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tphase.com/investor-relations
PDF WATERTOWN, Mass.--(BUSINESS WIRE)-- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializ [Read more]